The University of Chicago Header Logo

Connection

Jonathan Chung to Dose-Response Relationship, Drug

Back to Details
This is a "connection" page, showing publications Jonathan Chung has written about Dose-Response Relationship, Drug.
Jonathan Chung
Connection Strength
0.031
Dose-Response Relationship, Drug
  1. Pembrolizumab as Neoadjuvant Therapy Before Radical Cystectomy in Patients With Muscle-Invasive Urothelial Bladder Carcinoma (PURE-01): An Open-Label, Single-Arm, Phase II Study. J Clin Oncol. 2018 12 01; 36(34):3353-3360.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.